Sanara MedTech (SMTI) Earnings Analysis

Sanara MedTech (SMTI) next reports earnings on 2026-08-12, consensus EPS -0.07 USD. Last quarter (2026-05-11) it beat with EPS 0.04 USD vs -0.04 USD est (+200%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -6.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does SMTI next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.07 USD
Revenue estimate0.03B

SMTI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-110.04 USD-0.04 USD+200%Beat
2026-03-240.04 USD0.11 USD-63.6%Miss
2025-11-120.09 USD-0.24 USD+137.5%Beat
2025-08-13-0.23 USD-0.33 USD+30.3%Beat
2024-08-12-0.41 USD-0.21 USD-95.2%Miss

Beat rate: 3/5 (60%) over reported quarters with consensus data.

SMTI valuation and analyst view

Trailing P/E-6.55
Trailing EPS-3.8564 USD
Price / book31.64
Dividend yield0.00%
Market cap0.23B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)
Avg price target43 USD

Related research pages

Frequently asked questions

When is Sanara MedTech (SMTI)'s next earnings date?

Sanara MedTech is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.07 USD and revenue estimate of 0.03B.

Did SMTI beat earnings last quarter?

In its 2026-05-11 report, SMTI posted EPS of 0.04 USD versus a -0.04 USD estimate — a beat of 200%.

What is SMTI's earnings track record?

Over the last 5 reported quarters with consensus data, SMTI beat estimates 3 times (60%).

What is SMTI's current P/E ratio and EPS?

SMTI trades at a trailing P/E of -6.55 on trailing EPS of -3.856404474818065 USD.

What do analysts rate SMTI?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 43 USD.